Hemp Bombs CBD Pain Freeze Recalled Due to Subpotent Menthol Content
Hemp Bombs CBD Pain Freeze is being recalled because the menthol potency is less than the labeled 4%. Consumers should stop using the affected product and return it to the retailer.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall for subpotency in a drug product. The menthol content is below the labeled 4%. This potency mislabeling warrants Score 2 (Moderate) per the rubric's guidance that Class III recalls are typically scored 1 or 2.
Plain-English summary
Hemp Bombs CBD Pain Freeze is being recalled. The product is a menthol 4% topical pain relief cream in 1 oz bottles, manufactured by Global Widget LLC and distributed from 8419 Sunstate St, Tampa, Florida.
The recall is due to subpotency: the active ingredient (menthol) is less than the label claim of 4%. This means the product does not contain the amount of menthol consumers expect based on the label.
The affected products are distributed nationwide. The specific lot numbers involved are: Lot 230189 (expires April 2025), Lot 230335 (expires July 2025), and Lot 230351 (expires August 2025). Approximately 18,540 bottles are affected. The product has NDC 73423-003-01 and UPC 8-40078-56493-2.
Consumers who have this product should stop using it and discard it or return it to the retailer.
The recalled product
- Product
- Hemp Bombs CBD Pain Freeze (menthol 4%), 100mg, 1 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634, NDC 73423-003-01; UPC Code: 8-40078-56493-2
- Manufacturer
- GLOBAL WIDGET LLC
- Category
- Drug — Topical / Pain Relief
- Hazard
- subpotency
- labeling-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: 230189
- Exp. date Apr 2025
- 230335
- Exp. date Jul 2025
- 230351
- Exp. date Aug 2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27